EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ainos's enterprise value is $0.00 Mil.
Ainos's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.09 Mil. Therefore, Ainos's EV-to-Revenue for today is 0.00.
The historical rank and industry rank for Ainos's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Ainos was 25906.50. The lowest was -1799.44. And the median was 27.22.
AIMDW's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.105 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-12), Ainos's stock price is $0.0681.
Ainos's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Therefore, Ainos's PS Ratio for today is .
Ainos EV-to-Revenue Historical Data
The historical data trend for Ainos's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ainos's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ainos's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ainos's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Ainos's EV-to-Revenue falls into.
Ainos's current Enterprise Value is $0.00 Mil.
Ainos's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ainos's share price for today is $0.0681.
Ainos's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ainos EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Ainos's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AIMDW has been successfully added to your 